Aims To construct a program to predict the visual acuity (VA), best corrected VA (BCVA) and spherical equivalent (SE) of patients with retinopathy of prematurity (ROP) from 3 to 12 years old after ...

Aim To report the outcome of treatment of localised non-invasive ocular surface squamous neoplasia (OSSN) where topical 5-fluorouracil (5-FU 1%) is used as an adjuvant to surgical excision. Methods ...

Objective There has long been a great interest in neuroprotection therapy for ischaemic stroke and various types of optic neuropathies. In view of that, I reviewed the literature on the role of ...

Aim To explore the factors affecting surgical outcomes of highly myopic macular holes (HMMHs). Methods This is a retrospective cross-sectional study. Twenty-two eyes that underwent vitrectomy for ...

Background/aims Adalimumab (ADA) has been shown to be an effective treatment for Behçet’s disease (BD)-related uveitis. We aimed at evaluating the cumulative retention rate of ADA during a 48-month ...

AIM To evaluate the accuracy of impression cytology employing a Biopore membrane device in the diagnosis of ocular surface squamous neoplasia (OSSN). METHODS The histology of patients undergoing ...

The treatment of diabetic macular oedema (DMO) likely involves a series of treatment episodes separated by gaps during which ...

Background Acute dacryocystitis (AD) is primarily related to nasolacrimal duct obstruction and is associated with a high morbidity, particularly in the elderly. This study aims to determine ...

Background Diabetic retinopathy (DR) is a leading cause of blindness, with an increasing reliance on large language models ...

This study aims to assess the accuracy of CT imaging in estimating intraocular foreign body (IOFB) size by comparing pre-operative radiological measurements with post-surgical dimensions. A ...

Aim To assess if performing two visual field (VF) tests per eye on the same visit (frontloading) can increase perimetric data and decrease longitudinal variability compared with one test per eye.

Anti-vascular endothelial growth factor (VEGF) therapy has revolutionised the treatment of retinal disease, and appears to be very safe. Nevertheless, there are several lines of evidence that imply ...